Forecast: Production of Chemical and Pharmaceutical Products in the US

The production of chemical and pharmaceutical products in the US has seen considerable fluctuations from 2013 to 2023, with values peaking at 826.97 billion USD in 2013, witnessing a downturn until 2020, and rebounding to 880.41 billion USD in 2021. The year 2023 saw a slight uptick by 0.86% from the previous year, standing at 814.4 billion USD. Over the last 5 years, the compound annual growth rate (CAGR) averaged 0.32%, indicating a relatively stable growth trajectory post-recession.

Future trends to watch for include the projected consistent growth, with a forecast CAGR of 0.66% over the next five years. Key factors influencing this growth will likely entail advancements in biopharmaceuticals, policy changes, and market expansions. Monitoring technological innovations and regulatory landscapes will be critical for gauging production shifts in this sector.